COVID cases in India drop after government promotes 'Trump drugs'

 

India has become the center of the novel coronavirus pandemic, but a drop in cases has coincided with the national health ministry’s promotion of ivermectin and hydroxychloroquine treatments.

The India Ministry of Health and Family Welfare updated its guidelines on April 28 for treating the asymptomatic and those with mild symptoms of COVID-19

Since then, the data show cases have plunged in some areas, reported a leading promoter in the United States of ivermectin as a treatment for COVID-19, Dr. Pierre Kory, the COVID blog reported.

On Monday, Indian officials announced the country’s daily COVID-19 cases fell below 300,000 for the first time in 25 days.

Kory, the chief medical officer of the Front Line Covid-19 Critical Care Alliance, is known for his congressional testimony about the effectiveness of ivermectin. In a live Zoom conference May 13, he showed the promising data from various states in India in the two weeks since ivermectin has been promoted.

See Kory’s presentation:

India’s health agency is urging asymptomatic patients to consider taking 200 mcg/kg of ivermectin once a day on an empty stomach for three to five days. And caregivers of patients in quarantine are advised to “take Hydroxychloroquine prophylaxis as per protocol and as prescribed by the treating medical officer.”

Hydroxychloroquine has been dismissed by establishment media and government officials, particularly since it was promoted by President Trump. Last week, the Canadian Global Television Network called ivermectin and hydrochloroquine “two drugs that conspiracy theorists say cure COVID-19 and that scientists say are useless at treating the disease,” the COVID blog noted.

But there are 219 peer-reviewed studies indicating the effectiveness of hydroxychloroquine as a treatment and prophylaxis against COVID-19. And 54 peer-reviewed studies show the effectiveness of ivermectin as treatment and prophylaxis against COVID-19.

In February, a peer-reviewed study found that invermectin reduces coronavirus infections, hospitalizations and deaths by about 75%.

Ivermectin, in more than 30 trials around the world, causes “repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease,” according to the study, which was published in the U.S. journal Frontiers of Pharmacology.

The evidence is so strong, the researchers believe, the anti-parasitic drug should become a standard therapy everywhere, hastening global recovery.

“The data is overwhelming – we are in a pandemic, and this is an incredibly effective way to combat it. If we use ivermectin widely, our societies can open up,” said study co-author Professor Paul Marik, director of emergency and pulmonary care at Eastern Virginia Medical School.

A previous study by Professor Andrew Hill of Liverpool University also found ivermectin cuts death rates by about 75%.

‘Inaction in front of mounting evidence’

In a Senate hearing in December, Kory presented evidence that ivermectin prevents infection and saves lives.

“Although we, like many, are extremely encouraged by the apparent successes in developing effective vaccines, we also are dismayed at the near complete absence of guidance and research on effective early, at-home, or preventative treatment options apart from vaccines, a reality we find unconscionable,” he said in his statement.

Kory said he and his colleagues are “worried that if our call to action is not followed through, confidence in our health care leaders and agencies will be irreparably tarnished.”

“Inaction in front of mounting evidence of safety and effectiveness during a catastrophic pandemic may also compromise widespread vaccination support,” he warned.

“We will look back to the impact that actions versus inaction had on the U.S. and the globe two months from now,” Kory said. “If we do nothing, the present trend will continue. History will judge.”

See testimony of a life saved by ivermectin:

Politicization of treatments

Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health and Yale School of Medicine, is one of many health experts who decry the politicization of COVID-19 treatments such as ivermectin and hydroxychloroquine.

“You can hardly believe what anybody says anymore,” Risch said in an interview in December with Fox News’ Laura Ingraham. “We’ve lost 300,000 lives in the United States because our government has basic told everyone to go home, stay home, and if you can’t breathe, go to the hospital.”

That’s not a form of treatment, he said, “it’s what we call therapeutic nihilism.”

He said the federal government, through the FDA, CDC and National Institutes of Health, have misrepresented the benefits of the drugs.

“These are drugs that everywhere else in the world they are being used very effectively,” he said.

Risch contends the COVID-19 mortality rate is five times lower in the Third World “because that’s all they can afford to do.”

“And we’re here twiddling our thumbs and telling everyone to stay home. It’s absurd,” he said.

Content created by the WND News Center is available for re-publication without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact licensing@wndnewscenter.org.

SUPPORT TRUTHFUL JOURNALISM. MAKE A DONATION TO THE NONPROFIT WND NEWS CENTER. THANK YOU!

This article was originally published by the WND News Center.

Spread the word:
Email Newsletter

Sign Up for our Newsletter

Enter your best address below to receive the latest cartoons and breaking news in your email inbox:
Please wait...
You are successfully subscribed!
There was an error with subscription attempt.
Author

Content created by the WND News Center is available for re-publication without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact licensing@wndnewscenter.org.